BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 32484371)

  • 21. A Direct Comparison of 10 WAIS-IV Digit Span Embedded Validity Indicators among a Mixed Neuropsychiatric Sample with Varying Degrees of Cognitive Impairment.
    Resch ZJ; Cerny BM; Ovsiew GP; Jennette KJ; Bing-Canar H; Rhoads T; Soble JR
    Arch Clin Neuropsychol; 2023 May; 38(4):619-632. PubMed ID: 36244241
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impaired or invalid? Limitations of assessing performance validity using the Boston Naming Test.
    Abramson DA; Resch ZJ; Ovsiew GP; White DJ; Bernstein MT; Basurto KS; Soble JR
    Appl Neuropsychol Adult; 2022; 29(4):486-491. PubMed ID: 32538174
    [TBL] [Abstract][Full Text] [Related]  

  • 23. When 10 is enough: Errors on the first 10 items of the Test of Memory Malingering (TOMMe10) and administration time predict freestanding performance validity tests (PVTs) and underperformance on memory measures.
    Denning JH
    Appl Neuropsychol Adult; 2021; 28(1):35-47. PubMed ID: 30950290
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Examining the Clinical Utility of Selected Memory-Based Embedded Performance Validity Tests in Neuropsychological Assessment of Patients with Multiple Sclerosis.
    Lace JW; Merz ZC; Galioto R
    Neurol Int; 2021 Sep; 13(4):477-486. PubMed ID: 34698256
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cognitive impairment does not cause invalid performance: analyzing performance patterns among cognitively unimpaired, impaired, and noncredible participants across six performance validity tests.
    Critchfield E; Soble JR; Marceaux JC; Bain KM; Chase Bailey K; Webber TA; Alex Alverson W; Messerly J; Andrés González D; O'Rourke JJF
    Clin Neuropsychol; 2019 Aug; 33(6):1083-1101. PubMed ID: 30475095
    [No Abstract]   [Full Text] [Related]  

  • 26. Out of sight, out of mind: The impact of material-specific memory impairment on Rey 15-Item Test performance.
    Soble JR; Rhoads T; Carter DA; Bernstein MT; Ovsiew GP; Resch ZJ
    Psychol Assess; 2020 Nov; 32(11):1087-1093. PubMed ID: 32853003
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Convergent, Discriminant, and Concurrent Validity of Nonmemory-Based Performance Validity Tests.
    Webber TA; Critchfield EA; Soble JR
    Assessment; 2020 Oct; 27(7):1399-1415. PubMed ID: 30293445
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Impact of Learning and Memory on Performance Validity Tests in a Mixed Clinical Pediatric Population.
    Nayar K; Ventura LM; DeDios-Stern S; Oh A; Soble JR
    Arch Clin Neuropsychol; 2022 Jan; 37(1):50-62. PubMed ID: 34050354
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Word Memory Test genuine memory impairment profile discriminates genuine memory impairment from invalid performance in a mixed clinical sample with cognitive impairment.
    Alverson WA; O'Rourke JJF; Soble JR
    Clin Neuropsychol; 2019 Nov; 33(8):1420-1435. PubMed ID: 31002017
    [No Abstract]   [Full Text] [Related]  

  • 30. Specificity of Embedded Performance Validity Tests in Elderly Veterans with Mild and Major Neurocognitive Disorder.
    Kanser RJ; Logan PM; Steward KA; Vanderbleek EN; Kamper JE
    Arch Clin Neuropsychol; 2023 Jul; 38(5):772-781. PubMed ID: 36578198
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Derivation of New Embedded Performance Validity Indicators for the Child and Adolescent Memory Profile (ChAMP) Objects Subtest in Youth with Mild Traumatic Brain Injury.
    Brooks BL; MacAllister WS; Fay-McClymont TB; Vasserman M; Sherman EMS
    Arch Clin Neuropsychol; 2019 Jun; 34(4):531-538. PubMed ID: 30124740
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Assessing performance validity during attention-deficit/hyperactivity disorder evaluations: Cross-validation of non-memory embedded validity indicators.
    Ausloos-Lozano JE; Bing-Canar H; Khan H; Singh PG; Wisinger AM; Rauch AA; Ogram Buckley CM; Petry LG; Jennette KJ; Soble JR; Resch ZJ
    Dev Neuropsychol; 2022 Aug; 47(5):247-257. PubMed ID: 35787068
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Minimizing evaluation time while maintaining accuracy: Cross-validation of the Test of Memory Malingering (TOMM) Trial 1 and first 10-item errors as briefer performance validity tests.
    Kraemer LDR; Soble JR; Phillips JI; Webber TA; Fullen CT; Highsmith JM; Alverson WA; Critchfield EA
    Psychol Assess; 2020 May; 32(5):442-450. PubMed ID: 32027161
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cross-validation of three Advanced Clinical Solutions performance validity tests: Examining combinations of measures to maximize classification of invalid performance.
    Bain KM; Soble JR; Webber TA; Messerly JM; Bailey KC; Kirton JW; McCoy KJM
    Appl Neuropsychol Adult; 2021; 28(1):24-34. PubMed ID: 30987451
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Brief and cost-effective tool for assessing verbal learning in multiple sclerosis: Comparison of the Rey Auditory Verbal Learning Test (RAVLT) to the California Verbal Learning Test - II (CVLT-II).
    Beier M; Hughes AJ; Williams MW; Gromisch ES
    J Neurol Sci; 2019 May; 400():104-109. PubMed ID: 30913522
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Logical memory, visual reproduction, and verbal paired associates are effective embedded validity indicators in patients with traumatic brain injury.
    Tyson BT; Pyne SR; Crisan I; Calamia M; Holcomb M; Giromini L; Erdodi LA
    Appl Neuropsychol Adult; 2023 Mar; ():1-10. PubMed ID: 36881969
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Using the Grooved Pegboard Test as an Embedded Validity Indicator in a Mixed Neuropsychiatric Sample with Varying Cognitive Impairment: Cross-Validation Problems.
    Chang F; Cerny BM; Tse PKY; Rauch AA; Khan H; Phillips MS; Fletcher NB; Resch ZJ; Ovsiew GP; Jennette KJ; Soble JR
    Percept Mot Skills; 2023 Apr; 130(2):770-789. PubMed ID: 36634223
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of the classification accuracy of multiple performance validity tests in a mixed clinical sample.
    Messerly J; Soble JR; Webber TA; Alverson WA; Fullen C; Kraemer LD; Marceaux JC
    Appl Neuropsychol Adult; 2021; 28(6):727-736. PubMed ID: 31835915
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of credible patients of very low intelligence and non-credible patients on neurocognitive performance validity indicators.
    Smith K; Boone K; Victor T; Miora D; Cottingham M; Ziegler E; Zeller M; Wright M
    Clin Neuropsychol; 2014; 28(6):1048-70. PubMed ID: 24985490
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical utility of the Wechsler Memory Scale--Fourth Edition (WMS-IV) in predicting laterality of temporal lobe epilepsy among surgical candidates.
    Soble JR; Eichstaedt KE; Waseem H; Mattingly ML; Benbadis SR; Bozorg AM; Vale FL; Schoenberg MR
    Epilepsy Behav; 2014 Dec; 41():232-7. PubMed ID: 25461222
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.